Please note you are entering now content intended only for Healthcare Professionals.
Are you a HCP?
The Barrx™ radiofrequency ablation system includes the Barrx™ flex RFA energy generator and a family of ablation catheters which are designed to precisely control depth and uniformity of GI tissue ablation.9
Indications: The Barrx™ Channel RFA Endoscopic Catheter, Barrx™ 90, Barrx™ Ultra Long, and Barrx™ 60 RFA Focal Catheters and Barrx™ 360 Express RFA Balloon Catheter are indicated for use in the coagulation of bleeding and non-bleeding sites in the gastrointestinal tract, including but not limited to, Barrett’s esophagus and esophageal squamous cell neoplasia, defined as moderate grade intra-epithelial neoplasia (MGIN), high grade intra-epithelial neoplasia (HGIN), and/or early squamous cell carcinoma (SCC) of the esophagus limited to the lamina propria (i.e., T1m2).
Contraindications: Contraindications include pregnancy, prior radiation therapy to the esophagus, esophageal varices at risk for bleeding, prior Heller myotomy, and eosinophilic esophagitis.
Risk Information: The following are transient side effects that may be expected after treatment: chest pain, difficulty swallowing, painful swallowing, throat pain, and/or fever. Potential complications include mucosal laceration, minor or major bleeding, endoscopic clipping to manage mucosal laceration or bleeding, perforation of the stomach, oesophagus or pharynx, surgery to manage perforation, esophageal stricture, endoscopic dilation to manage stricture, pleural effusion, transfusion secondary to major bleeding, cardiac arrhythmia, aspiration, infection, and death.